LEADER 01169nam  22004095u 450 
001 9910156317903321
005 20211006145350.0
010   $a3-318-03417-7
035   $a(CKB)3780000000102168
035   $a(OCoLC)1046111201
035   $a(SZ-BaSKA)221689
035   $a(EXLCZ)993780000000102168
100   $a20211006d1989      uy             0
101 0 $aeng
135   $aurunu|||||
200 10$aThe Chemotherapy of Malignant Diseases : $eResearch Perspectives / $f H.H. Sedlacek
210   $aBasel : $cS. Karger, $d1989
215   $a1 online resource (X + 154 pages) : $c  10 figures, 34 tables
311   $a3-8055-4965-2 
517   $aChemotherapy of Malignant Diseases
606   $aOncology
606   $aPharmaceutics
606   $aPharmacology
606   $aImmunology
615 14$aOncology
615 14$aPharmaceutics
615 14$aPharmacology
615 24$aImmunology
676   $a616.99/4061
700   $aSedlacek$b H.H
701  0$aSedlacek$b H. H$0863253
801  0$bUKSKG
801  1$bUKSKG
906   $aBOOK
912   $a9910156317903321
996   $aThe Chemotherapy of Malignant Diseases$92866422
997   $aUNINA